医疗保健 CRO 服务市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00010465
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 223
Buy Now

[研究报告]2019年医疗保健合同研究组织(CRO)服务市场价值为4320857万美元,预计2027年将达到8785908万美元;预计 2020 年至 2027 年复合年增长率为 9.5%。

合同研究组织 (CRO) 在整个产品开发过程中为制药、生物技术和医疗器械公司提供支持服务。医药&生物技术公司和医疗器械行业需要各种测试服务,如临床前服务、临床研究服务、分析测试服务、生物分析测试服务和监管服务。 CRO 专门用于执行这些测试服务,以减少公司进行广泛的测试服务以符合国家和国际监管标准所需的内部成本和时间。全球医疗保健CRO服务市场的增长归因于临床试验数量的增加以及研发和外包活动支出的增加。然而,缺乏熟练的专业人员是阻碍医疗保健 CRO 服务市场

增长的主要因素。


报告覆盖范围

全球医疗保健合同研究组织 (CRO) 服务市场预计将在大流行后出现大幅增长。由于封锁、旅行禁令和企业关闭,COVID-19 已经影响了各国的经济和行业。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着 COVID-19 大流行的进展,医疗保健行业的增长预计将下降。由于体外诊断产品需求的增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于进行的手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断以及随后药物上市的延迟预计也将为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将出现并改变制药行业,未来几年市场预计还将出现更多的垂直整合和合资企业。

全球医疗保健 CRO 服务市场利润丰厚的地区


市场洞察

临床试验数量不断增加,推动全球医疗保健合同研究组织 (CRO) 服务市场增长

临床试验在药物审批及其对疾病的疗效中发挥着决定性作用。这些研究有助于了解某些治疗领域的最佳医疗方法。世界各地的医疗保健系统正在观察临床试验数量的快速增加。对新药和医疗设备的需求不断增长、慢性病患病率不断上升以及临床试验资助计划的增加等因素推动了全球临床试验的数量。

此外,许多公司专注于与合同研究组织建立合作伙伴关系,以有效地开展临床研究。例如,2019 年 12 月,Cyclo Therapeutics 与合同研究组织 Worldwide Clinical Trials 签署了服务协议,以执行公司的项目。临床计划,用于评估 Trappsol Cyclo 治疗阿尔茨海默病的方法。此外,2020 年 5 月,Dare; Bioscience, Inc. 与大型合同研究组织 Health Decisions, Inc. 建立了战略合作伙伴关系,以加速女性健康项目的临床研究。合作数量的不断增加最终将增加合同研究组织在临床研究执行中的贡献,从而最终推动市场增长。

基于服务类型的洞察

就服务类型而言,全球医疗保健合同研究组织(CRO)服务市场分为早期开发、实验室服务、咨询服务和临床研究服务。 2019年,临床研究服务领域占据最大市场份额。此外,预计同一细分市场在预测期内的复合年增长率最高。

全球医疗保健 CRO 服务市场(按服务类型) 2019年和2027年


 

基于治疗适应症的见解

在治疗适应症方面,全球医疗保健合同研究组织(CRO)服务市场细分为肿瘤学、传染病、免疫性疾病、呼吸系统疾病、心血管疾病、神经系统疾病等。 2019年,其他细分市场占据最大市场份额。然而,肿瘤学领域预计在预测期内复合年增长率最高。

基于最终用户的见解

就最终用户而言全球医疗保健合同研究组织(CRO)服务市场分为医疗器械公司、制药和生物制药公司以及其他(学术机构)。制药和生物制药公司细分市场在 2019 年占据了最大的市场份额。此外,预计该细分市场在预测期内将以最高的复合年增长率增长。

战略洞察

全球医疗保健 CRO 服务市场参与者正在采用产品推出和扩张策略来满足全球不断变化的客户需求,这也使他们能够在全球范围内保持品牌声誉。

< h3> 

全球医疗保健 CRO 服务市场 –按服务类型

  • 早期开发
    • 发现研究
    • 化学、制造和控制
    • 临床前服务
    • li>
  • 实验室服务
    • 生物分析测试
    • 分析测试
  • 咨询服务
  • 临床研究服务
    • 第一阶段
    • 第二阶段
    • 第三阶段
    • 第四阶段

全球医疗保健 CRO 服务市场 –按治疗适应症

  • 肿瘤学
  • 传染病
  • 呼吸系统疾病
  • 心血管疾病
  • 神经系统疾病
  • 其他  

全球医疗保健 CRO 服务市场  按最终用户划分

  • 医疗器械公司
  • 制药和生物制药公司
  • 其他(学术机构)

全球医疗保健 CRO 服务市场 –按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
  • < /ul>

    公司简介

    • Charles River Laboratories, Inc.
    • Iqvia Inc.
    • 美国控股实验室公司
    • Parexel International Corporation
    • Icon Plc
    • PRA Health Sciences
    • Syneos Health
    • Medpace
    • 药明康德
    • PPD Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the Healthcare Contract Research Organization (CRO) services market across the globe?

Factors like growing number of clinical trials and increasing expenditure in R&D and outsourcing activities are driving the growth of the market. In addition, rising biosimilars and biologics market are likely to have a positive impact on the growth of the market in the coming years.

What is the average cost of a clinical trial?

The clinical trials cost a median of $41,117 per patient and $3,562 per patient visit. Clinical trial cost varies with the therapeutic area, phase of study and region where the clinical trial is being conducted.

What are Healthcare Contract Research Organization (CRO)?

Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical& biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards..

The List of Companies - Healthcare Contract Research Organizations (CRO) Services Market

  1. Charles River Laboratories Inc.
  2. IQVIA Inc.
  3. Laboratory Corporation of America Holdings
  4. Parexel International Corporation
  5. Icon Plc.
  6. Pra Health Sciences
  7. Syneos Health
  8. Medpace
  9. Wuxi Apptec
  10. PPD Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports